Molecular screening to select therapy for advanced cancer?
Ann Oncol
.
2019 May 1;30(5):661-663.
doi: 10.1093/annonc/mdz088.
Authors
I F Tannock
1
,
J A Hickman
2
Affiliations
1
Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada. Electronic address: ian.tannock@uhn.ca.
2
126 boulevard Pereire, Paris, France.
PMID:
30865225
DOI:
10.1093/annonc/mdz088
No abstract available
Publication types
Editorial
Comment
MeSH terms
Early Detection of Cancer
Humans
Mass Screening
Neoplasms*
Neoplasms, Second Primary*